Online Cognitive Behavioural Therapy (CBT) versus mindfulness for depression and anxiety: a randomised controlled trial

Not Applicable

Active, not recruiting

• Conditions: Major Depressive Disorder; Generalised anxiety disorder; Social anxiety disorder; Panic disorder; Agoraphobia; Obsessive Compulsive Disorder; Mental Health - Anxiety; Mental Health - Depression

• Registration Number: ACTRN12617001538336
• Lead Sponsor: SW Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-11-06
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

* Self-identified as experiencing depression and/or anxiety.
* Meet criteria for one or more of the following diagnoses: Major Depressive Disprder (MDD), Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), Panic Disorder (PD), Agoraphobia (AG), or Obsessive-Compulsive Disorder (OCD) according to the ADIS-5 for DSM-5.
* Australian resident status
* At least 18 years of age
* Access to a computer, printer, and the internet
* If taking medication, must have been taking the same dose for at least 2 months and not intend to change that dose during the course of the program.
* Prepared to provide name, phone number, and address, and to provide the name and phone number of a local general practitioner.
* Willing to provide informed consent.

Exclusion Criteria

Does not meet diagnostic criteria for an anxiety or depressive disorder.
- Currently experiencing severe depression symptoms (score of 23 or above on the PHQ-9).
- Regularly using illicit drugs or regularly consuming more than three standard drinks per day
- Current regular use of benzodiazepines
- Current use of atypical anti-psychotics
- Currently experiencing a psychotic mental illness or bipolar disorder
- Completed an online program for depresison and/or anxiety in the past year
- Current Post traumatic stress disorder (PTSD)
- Currently suicidal and/or severe symptoms of suicidal ideation (defined as responding 3 to the PHQ-9 question 9 item that assesses the frequency of suicidal ideation over the past fortnight).
-Those scoring 1 or 2 on the Patient Health Questionnaire-9 Item (PHQ-9) item 9 will require risk assessment with the responsible clinician before being admitted into the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in depression symptoms (according to mean scores on the Patient Health Questionnaire (PHQ-9)[Baseline, mid-treatment (before Lesson 4), one week post-treatment (week 11), and at 6-month post-treatment (week 34). Primary time-point is post-treatment (week 11).];Changes in anxiety symptoms according to mean scores on the Generalised Anxiety Disorder 7-item scale (GAD-7).[Baseline, mid-treatment (before Lesson 4), one week post-treatment (week 11), and at 6-month post-treatment (week 34). Primary time-point is post-treatment (week 11).]